Guest lecture by Dr. Özlem Türeci: RNA-based therapeutics and personalized neoantigen cancer vaccines

From the Nobel Committee at Karolinska Institutet on awarding the Nobel Prize in Physiology or Medicine 2023 to Katalin Karikó og Drew Weissmann:

"When the pandemic broke in early 2020, mRNA companies acted quickly to develop COVID-19 vaccines. BioNTech and Moderna chose to use mRNA with modified bases building on the discoveries by Karikó and Weissmann. BioNTech, with Uğur Şahin and Özlem Türeci in the lead, worked in partnership with Pfizer"

This essential work served humanity during the COVID-19 pandemic. Read more about the Nobel Prize in Medicine or Physiology 2023

Time and place: Nov. 16, 2023 2:00 PM – 3:00 PM, Kaare Norum Auditorium, 2nd floor Oslo Cancer Cluster Incubator, Ullernchausseen 64, 0379 Oslo

Distinguished guest lecture by Dr. Özlem Türeci, Chief Medical Officer, BioNTech and Professor, Mainz University Medical Ctr & Helmholtz Institute for Translational Oncology

This event requires registration. Please register here

Abstract: “My talk at the University will be a scientific, technological one directed to an expert scientific and clinical audience with strong background in immunology and oncology. I may cover 2 topics if time allows: preclinical-clinical development of RNA cancer vaccines and a new CAR T cell”

Organizers: Institute for Cancer Research, Oslo University Hospital, CoE PRIMA, University of Oslo, and Norwegian Society for Immunology

Contacts: kjetil.tasken@medisin.uio.no and johanna.olweus@medisin.uio.no

NB: Dr. Türeci will also give a talk at 18:00 in the Norwegian Academy of Science and Letters with the title: "Vaccines: mRNA vaccine technology - COVID-19, Cancer & beyond". Registration to Line Therese Nævestad: l.t.navestad@dnva.no

See more information at the DNVA website

Published Sep. 14, 2023 3:24 PM - Last modified Nov. 15, 2023 2:39 PM